Results 221 to 230 of about 47,580 (341)

Correction: Bispecific antibody for lung cancer: mechanisms and clinical insights. [PDF]

Front Immunol
Chen W, Zhou A, Zhou Y.
europepmc   +1 more source

FLT3/CD99 Bispecific Antibody–Based Nanoparticles for Acute Myeloid Leukemia

Atham Ali, Alvin Phan, Vijaya Vaikari, Mincheol Park, Mateusz Pospiech, Ryan Chu, Yiting Meng, J. Andrew MacKay, Houda Alachkar   +8 more
openalex   +1 more source

Primary Cutaneous B‐Cell Lymphomas: An Updated Portrait of Classification, Biology, and Clinical Management

European Journal of Haematology, Volume 116, Issue 2, Page 116-128, February 2026.
ABSTRACT Primary cutaneous B‐cell lymphomas (CBCL) represent a clinically and biologically heterogeneous group of extranodal non‐Hodgkin lymphomas confined to the skin at the time of diagnosis. They account for approximately 25% of all primary cutaneous lymphomas and are subclassified into distinct entities according to the World Health Organization ...
A. Bernardelli, E. Carazzai, B. Bugnotto, F. Bellinato, M. Krampera, C. Visco   +5 more
wiley   +1 more source

Phase 1 dose-escalation study of IBI324, a VEGF-A/Ang-2 bispecific antibody, for the treatment of diabetic macular oedema. [PDF]

BMJ Open Ophthalmol
Wang Z, Sun J, Liu K, Tao L, Liu Q, Wu M, Lu S, Deng J, Li L, Qian L, Li X, Sun X.   +11 more
europepmc   +1 more source

AMCP Market Insights: Managed care approaches to bispecific antibodies with a focus on follicular lymphoma and diffuse large B-cell lymphoma

Bridget Flavin, Denise Wolff, Laura Rose Bobolts, Tara Graff, Kirollos S. Hanna, Ryan Haumschild, Timothy Mok, Bhavesh Shah   +7 more
openalex   +2 more sources

Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site [PDF]

, 2012
Thomas List, Dario Neri
openalex   +1 more source

T‐cell surface generation of dual bivalent, bispecific T‐cell engaging, RNA duplex cross‐linked antibodies (dbBiTERs) for re‐directed tumor cell lysis

, 2021
Maciej Kujawski, Li Lin, Harry Li, Paul J. Yazaki, Piotr Swiderski, John E. Shively   +5 more
openalex   +2 more sources

Bispecific Antibody 4G7xH22 [PDF]

, 2020
openaire   +1 more source

T‐Cell–Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions

European Journal of Haematology, Volume 116, Issue 2, Page 129-141, February 2026.
ABSTRACT Relapsed/refractory (R/R) mantle cell lymphoma (MCL) remains a therapeutic challenge, particularly in patients with high‐risk features or prior exposure to Bruton's tyrosine kinase inhibitors (BTKis). The advent of T‐cell–redirecting immunotherapies, including chimeric antigen receptor T‐cell (CAR‐T) therapy and bispecific antibodies (BsAbs ...
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Characterization of free light chain impurity in a bispecific antibody. [PDF]

MAbs
Sadek M, Mantha N, Lippold S, Li D, Spitler K, Li R, Spinosa P, Liu B, Luu S, Woon N, Zhang Y, Guo J, Yang R, Zarzar J, Yang Y.   +14 more
europepmc   +1 more source